Tag | Content |
---|
EnhancerAtlas ID | HS115-01178 |
Organism | Homo sapiens |
Tissue/cell | Kidney_cortex |
Coordinate | chr13:41591280-41593360 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
ZNF263 | MA0528.1 | chr13:41591718-41591739 | ACCCCCCCTTCTCCCTTCTCC | - | 6.55 |
|
| Number of super-enhancer constituents: 30 | ID | Coordinate | Tissue/cell |
SE_09221 | chr13:41588268-41594981 | CD14 | SE_10387 | chr13:41591054-41594336 | CD19_Primary | SE_10999 | chr13:41586782-41594964 | CD20 | SE_12017 | chr13:41591113-41594408 | CD3 | SE_12860 | chr13:41591107-41594210 | CD34_Primary_RO01480 | SE_13324 | chr13:41591123-41594688 | CD34_Primary_RO01536 | SE_14054 | chr13:41591043-41594008 | CD34_Primary_RO01549 | SE_14557 | chr13:41591019-41594655 | CD4_Memory_Primary_7pool | SE_17089 | chr13:41591090-41593939 | CD4p_CD225int_CD127p_Tmem | SE_17551 | chr13:41591106-41594888 | CD4p_CD25-_CD45RAp_Naive | SE_18001 | chr13:41587961-41594231 | CD4p_CD25-_CD45ROp_Memory | SE_18357 | chr13:41586465-41594682 | CD4p_CD25-_Il17-_PMAstim_Th | SE_20204 | chr13:41591008-41594260 | CD56 | SE_22365 | chr13:41591055-41594316 | CD8_primiary | SE_25440 | chr13:41591096-41594870 | DND41 | SE_26079 | chr13:41591111-41596208 | Duodenum_Smooth_Muscle | SE_27818 | chr13:41591048-41596772 | Fetal_Intestine | SE_28717 | chr13:41589113-41596566 | Fetal_Intestine_Large | SE_31205 | chr13:41591057-41594339 | Fetal_Thymus | SE_32532 | chr13:41591085-41593864 | GM12878 | SE_35394 | chr13:41591129-41595366 | HepG2 | SE_39455 | chr13:41591106-41593720 | Jurkat | SE_44094 | chr13:41591111-41593840 | MM1S | SE_55509 | chr13:41591230-41591759 | Thymus | SE_58302 | chr13:41534094-41596249 | Ly1 | SE_60466 | chr13:41534866-41594996 | DHL6 | SE_61682 | chr13:41555019-41595174 | Toledo | SE_62237 | chr13:41534318-41594936 | Tonsil | SE_64637 | chr13:41591143-41594546 | NHEK | SE_66291 | chr13:41591106-41593720 | Jurkat |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | GCATCATCTT TCTGATGAAA AAGAAAACTA CATTTTCAAA ATCATTGGTT GATCCATTTG 60 GTTGCAACTT ATCACCAAGA TTATCACCAA ACATCTTAAT TAAGGTTTTA TTTACTCTTA 120 AGGAAATATA GAGCATTTCA AACAAAGCAT CACTTGTGAC TGGCACAAGC AGTTCCAGAC 180 TGCGAAGCCC TGCCATTAGG TACTGCATGA CCTCAAGCAA ATCACAGGAC CTCTGTGGGC 240 CACTGTTTCT TCATCTATAA AAGTGAGGCA GTTGGACAAT CTTCAGTCAC TTTCAGCACT 300 AAAGTTCTAT AAATCACTAA TTCTAAATTT AATTCTGATG GGTCAGTTCA AACTTACATT 360 CAATCTTATG GAAGGAAAAA CGTGGAGAGG GAAATACTTA ATAAATTGTT CTGGTCTTTT 420 CTTGGTTCTC TTCTTTTTAC CCCCCCTTCT CCCTTCTCCT TGAAACTCCA CTTCAGTCTC 480 TATCACGTAA GAAAATACAT AAACAATATC TATACTACTT TAACTGTACC AGCTTCTTAA 540 ATTTAAGAAA CCAAATTCCT CTACTTCTCT TTAATAAATA AGATCTTAAT TATGCCGCTT 600 ATTTGTGTGC CTCTTGATTT TTCTCTTATG GATCACCACC TTAAAAAAGT TAAAAAAAAA 660 AATAGAAAAG TCTTCATTAG ATTTTTCACA CAGACCAGAC TAGAAGTAAA TACAGCTTTT 720 GCTTACTCAA AGGCTGACTA AACCAGCAAT ATGCAAACAA AGATGATAGC AAATGGCTCA 780 GCTGAATTGG TAAAATGTCC GCTGTGTCTT TCTTGTAAGA CCGCAAAATT GAGATCTGTT 840 AATATCAACA ATCCTTACAA AAGAGTAAGA AATAATAACT GATTGCCTTT GTCTCTTCCC 900 TTTAATCTGA CAGGCCTTCA AGCACTTAGT AAGTGCATAG CAAATTCTCA AAGAACTAGC 960 TAAATATCAT TTTGGTCAAC AAGAAATGAT TTGGCAAGTT TTATATCCAA AAACTTTATT 1020 TTTTGGAATC ACTGCATATT CCAATTTTAT CTTCATAAAT ATGTTTCAGA AATAAAATAC 1080 TACTGCACTC ATCTTTACAG AGCACCTAGA ACTTTAAGGC ACAGTAGGAT GTATACTTGC 1140 CAGCCAAAAT CTCATAACTA CAATGACAAG TACTTCAGGA AAAGACTGAG CAATCTTTTC 1200 ATTTACAGAA GGTTTTTAAT TCAAGGCAGG CAAATTTTAA GAACAGTAAT ACAAAAGGAA 1260 GGCCAATACT CATCACTTTT TCTTTTTACA CAAAATTGAA ATAACTACGT TTCCTTAGAA 1320 GACAGCTTTA CTTCTAAGGT TGTTACTCAG AACAAGTTTT CAGTGTGAAT TATAAAACTT 1380 CATTTTTTTC TAATAGTAAA TGAATCATTC TAGTCTTTCT TCCTCTATTT AATATTCACT 1440 TTTACTTGTT ATCTAAATAA TCTAATATTC ATTTTTACTT ATTATCTAAA TAACAATTCA 1500 TTTAAATTTC CATTGGGTTT CCAAAATGAA ACATTTAATA TAATTTCATT AACTTTAAAA 1560 AACAGAGAGG GAGAAAAAAA TAAATAAATA ACAGTCAATG AGCAACACCT ATGGCTGAGT 1620 TGTCCCAAAA CTTCACCCTT AGCTAAAATG CCAAAACAAA GCCACTGCCC CTGGATATTT 1680 AACATCTATA TCACACAGGA ATAATACGGT TTACTTAACT GTAACTTCAA CTACCCCAAA 1740 AAATACAATT AGGTTTTTTA AATTAAAATT TGACCTTAGT TTGCTTTGTG GTACTTAAAA 1800 ACAAATAAAC AAACAAAAAA CCTCTTTTAT TCTTAAATTA CATAGAAAAA AAATCACAAA 1860 GACATACAAA ATGCTTTAGC AAGAAGATCT AAAACTTTCC AGAATTTCAG TGCTTTGTTT 1920 CCCCCTAGCA ATTAAGTTCA ATCAGGCATG TGACTGACCA CACACATTTT ATCAGAGGGT 1980 TAAAGAACAC ATTCAGCCAT GTTCTTCAAC AGGTAAGAAC CACCCTCTGT TTATCAGCTC 2040 AAGAAAAAGC CAGAAGCAAA CATACAAAAT TGTAACAAGT 2080
|